Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihee Kim

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII|May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cellsVan-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Annals of Laboratory Medicine|May 12, 2025
Chromosomal Rearrangements in 1,787 Cases of Acute Leukemia in Korea over 15 yearsDongGeun Son, Ho Cheol Jang, Young Eun Lee, et al.
Sensors (Basel, Switzerland)|December 11, 2025
Novel Wearable-Based Real-Time Temperature Monitoring in Hospitals for Febrile Adverse Events in Patients with Cancer: A Prospective Feasibility StudyYun Kwan Kim, Seo-Yeon Ahn, Sun Jung Lee, et al.
Cancer Research and Treatment|November 12, 2025
Prognostic Factors for Relapse and the Role of Maintenance Therapy in Acute Promyelocytic Leukemia: A Real-World Multicenter Study in KoreaKunye Kwak, Mihee Kim, Dongjin Shin, et al.
Cancer Research and Treatment|January 26, 2023
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid LeukemiaSeo-Yeon Ahn, TaeHyung Kim, Mihee Kim, et al.
Bone Marrow Transplantation|December 6, 2020
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencingJae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Bone Marrow Transplantation|September 23, 2022
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemiaGa-Young Song, TaeHyung Kim, Seo-Yeon Ahn, et al.
Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII|May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cellsVan-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Annals of Laboratory Medicine|May 12, 2025
Chromosomal Rearrangements in 1,787 Cases of Acute Leukemia in Korea over 15 yearsDongGeun Son, Ho Cheol Jang, Young Eun Lee, et al.
Sensors (Basel, Switzerland)|December 11, 2025
Novel Wearable-Based Real-Time Temperature Monitoring in Hospitals for Febrile Adverse Events in Patients with Cancer: A Prospective Feasibility StudyYun Kwan Kim, Seo-Yeon Ahn, Sun Jung Lee, et al.
Cancer Research and Treatment|November 12, 2025
Prognostic Factors for Relapse and the Role of Maintenance Therapy in Acute Promyelocytic Leukemia: A Real-World Multicenter Study in KoreaKunye Kwak, Mihee Kim, Dongjin Shin, et al.
Cancer Research and Treatment|January 26, 2023
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid LeukemiaSeo-Yeon Ahn, TaeHyung Kim, Mihee Kim, et al.
Bone Marrow Transplantation|December 6, 2020
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencingJae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Bone Marrow Transplantation|September 23, 2022
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemiaGa-Young Song, TaeHyung Kim, Seo-Yeon Ahn, et al.
Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.
Pageof 6